Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Drug Delivery

Read more breaking news


News in brief

West and Amgen sign Crystal Zenith evaluation deal

Last updated on 21-Jun-2012 at 09:52 GMT2012-06-21T09:52:37Z

West and Amgen sign Crystal Zenith evaluation deal

West Pharmaceutical Services has inked a deal with Amgen to evaluate its Crystal Zenith technology for drug containment.

Crystal Zenith was developed by Daikyo Seiko, a partner of West, to avoid problems associated with using glass vials. Amgen encountered these shortcomings in 2010 when a recall of vials containing glass flakes cost it tens of millions of dollars.

Biopharmaceutical therapeutic products require a drug container that enables safe, effective and reliable containment,” Donald Morel, CEO of West, said. Amgen and West have a long-standing relationship and the Crystal Zenith deal builds on their earlier business dealings.

Key Industry Events

CPhI North America

Philadelphia, PA, USA / Conference and exhibition

Read more

Access all events listing